A comprehensive study from Karolinska Institutet shows that people with fatty liver disease have almost twice the mortality ...
Ipsen has taken rights to PPAR agonist elafibranor as a treatment for primary biliary cholangitis – a chronic, autoimmune disease in which bile ducts in the liver are gradually destroyed causing ...
School of Chemical Sciences, University of Chinese Academy of Sciences, Beijing 100049, P. R. China ...